Asprosin in Cardiovascular Disease: Mechanistic Insights, Context-Dependent Effects, and Translational Perspectives

Announcing a new article publication for Cardiovascular Innovations and Applications journal highlighting the asprosin biology in the cardiovascular system. The study investigates molecular signaling pathways and tissue‑specific effects, moving beyond a disease‑centered descriptive framework, carefully differentiating exploratory hypotheses from validated conclusions, thereby strengthening the foundation for precision cardiovascular research and therapeutic innovation.

The study also emphasize that future progress in this field should depend on rigorous experimental designs integrated with well‑structured clinical investigations, ensuring that hypothesis‑generating insights aretranslated into evidence‑based conclusions for precision medicine.

# # # # # #

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Lutfu Askin, Okan Tanriverdi and Veysel Ozgur Baris et al. Asprosin in Cardiovascular Disease: Mechanistic Insights, Context-Dependent Effects, and Translational Perspectives. CVIA. 2026. Vol. 11(1). DOI: 10.15212/CVIA.2026.0012

CVIA Journal